 |  |  |  |
 |  |  |  |
 |  |  |  |
 | |||
Categories:
- Business News (rss) (9782)
Archives:
- January 2009 (139)
- December 2008 (940)
- November 2008 (1190)
- October 2008 (1281)
- September 2008 (1097)
- August 2008 (946)
- July 2008 (1033)
- June 2008 (963)
- May 2008 (836)
- April 2008 (926)
- March 2008 (415)
- December 2007 (16)
Dutch cenbank halts Fortis ABN Dutch assets sale
September 30, 2008 on 7:02 pm | In Business News | No CommentsAMSTERDAM/BRUSSELS (Reuters) - The Dutch central bank is withholding approval for Fortis NV’s sale of 709 million euros (561 million pounds) worth of Dutch ABN AMRO assets to Deutsche Bank AG in order to meet European antitrust demands, Fortis said on Tuesday.
Stocks rally as Bush pushes revived bailout
September 30, 2008 on 4:57 pm | In Business News | No CommentsNEW YORK/WASHINGTON (Reuters) - U.S. lawmakers and President George W. Bush eased pressure on financial markets on Tuesday by starting work to revive a $700 billion (388 billion pound) bailout plan to stem a credit crisis that has spread beyond Wall Street to claim more European banks.
Read more from the original source:
Stocks rally as Bush pushes revived bailout
U.S. stocks rally on bailout hope
September 30, 2008 on 4:46 pm | In Business News | No CommentsNEW YORK (Reuters) - The dollar surged and U.S. stocks jumped on Tuesday, recouping more than half the losses sustained from Wall Street’s worst day in 20 years, on growing optimism Washington will find a way to rescue troubled banks.
Original post:
U.S. stocks rally on bailout hope
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
Here is the original post:
Big Pharma prunes R&D as times get tough
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
Original post:
Big Pharma prunes R&D as times get tough
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
Read more from the original source:
Big Pharma prunes R&D as times get tough
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
See the rest here:
Big Pharma prunes R&D as times get tough
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
Excerpted from:
Big Pharma prunes R&D as times get tough
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
Go here to see the original:
Big Pharma prunes R&D as times get tough
Big Pharma prunes R&D as times get tough
September 30, 2008 on 4:15 pm | In Business News | No CommentsLONDON/NEW YORK (Reuters) - Faced with sickly investment returns, the world’s top drugmakers are taking the knife to research and development.
View original here:
Big Pharma prunes R&D as times get tough
Entries and comments feeds.
Valid XHTML and CSS